CASTRATION-SENSITIVE PROSTATE CARCINOMA
Clinical trials for CASTRATION-SENSITIVE PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-SENSITIVE PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for CASTRATION-SENSITIVE PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to crush prostate cancer spread
Disease control OngoingThis study tests a combination of three drugs (apalutamide, abiraterone, and prednisone) given after chemotherapy to men with advanced prostate cancer that has spread and has not been treated before. The goal is to see if this hormone therapy can lower PSA levels more effectively…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Could a hormone therapy vacation help prostate cancer patients recover testosterone?
Disease control OngoingThis study looks at whether men with metastatic prostate cancer that has responded extremely well to hormone therapy can safely take a break from treatment. The goal is to see if pausing therapy allows their testosterone levels to return to normal, potentially improving quality o…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC